(Q42984181)

12 November 2017

title

Spontaneous clearance of HCV in HIV-hepatitis C virus coinfected liver transplant patients: prospective study (English)

1 reference

Francisco Javier Padillo Ruiz

12 November 2017

1 reference

1 reference

ORCID Public Data File 2021

author name string

M Gutiérrez-Moreno

1

1 reference

12 November 2017

C Bernal-Bellido

2

1 reference

12 November 2017

G Suárez-Artacho

3

1 reference

12 November 2017

J M Alamo-Martínez

4

1 reference

12 November 2017

L M Marín-Gómez

5

1 reference

12 November 2017

J Serrano-Díaz-Canedo

6

1 reference

12 November 2017

F J Padillo-Ruiz

7

1 reference

12 November 2017

M A Gómez-Bravo

8

1 reference

12 November 2017

language of work or name

English

0 references

publication date

1 September 2012

1 reference

Transplantation Proceedings

12 November 2017

published in

1 reference

12 November 2017

volume

44

1 reference

12 November 2017

issue

7

1 reference

12 November 2017

page(s)

2100-2102

1 reference

Long-term outcomes of liver transplant patients with human immunodeficiency virus infection and end-stage-liver-disease: single center experience

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

High prevalence of HIV-1 and hepatitis C virus coinfection among injection drug users in the southeastern region of Yunnan, China.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

Survival of liver transplant patients coinfected with HIV and HCV is adversely impacted by recurrent hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

[Liver transplantation in patients with HIV infection]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

Survival and recurrence of hepatitis C after liver transplantation in patients coinfected with human immunodeficiency virus and hepatitis C virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

Factors influencing a low rate of hepatitis C viral RNA clearance in heroin users from Southern China

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

Interferon-alpha and ribavirin for the treatment of recurrent hepatitis C after liver transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

Nanomedicines in the treatment of patients with hepatitis C co-infected with HIV--focus on pegylated interferon-alpha

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

Should HIV/HCV coinfected patients with severe hepatitis be treated for hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

Spontaneous clearance of hepatitis C virus after liver transplantation in two patients coinfected with hepatitis C virus and human immunodeficiency virus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

Antiviral treatment of recurrent hepatitis C after liver transplantation: predictors of response and long-term outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

Survival of Human Immunodeficiency Virus–Infected Liver Transplant Recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2012.07.074

10.1016/J.TRANSPROCEED.2012.07.074

7 January 2021

Identifiers

DOI

1 reference

12 November 2017

1 reference